CNS Pharmaceuticals (CNSP) Institutional Ownership $9.40 -0.31 (-3.14%) As of 02:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)CurrentInstitutional OwnershipPercentage14.02%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$144.41MNumber ofInstitutional Sellers(last 12 months)0 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CNSP Institutional Buying and Selling by Quarter CNS Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Armistice Capital LLC406,000$335K0.0%N/A90.222% 2/18/2025Connective Capital Management LLC280,055$34K0.0%N/A0.487% 2/17/2025Citadel Advisors LLC321,874$39K0.0%N/A0.560% 2/14/2025Jane Street Group LLC419,737$51K0.0%+1,712.3%0.730% 2/14/2025Integrated Wealth Concepts LLC250,000$30K0.0%N/A0.435% 2/13/2025XTX Topco Ltd294,919$36K0.0%N/A0.513% 2/12/2025Geode Capital Management LLC387,064$47K0.0%+90.5%0.673% 2/7/2025Wealthfront Advisers LLC216,046$26K0.0%N/A0.376% 5/20/2024Virtu Financial LLC94,246$34K0.0%+616.6%0.795% 2/13/2024Armistice Capital LLC122,000$155K0.0%N/A1.965% 1/17/2024Smith Anglin Financial LLC50,000$64K0.0%N/A0.952% 8/7/2023Acadian Asset Management LLC22,292$49K0.0%N/A1.000% 7/12/2023FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732% 9/17/2021Virtu Financial LLC20,745$41K0.0%-49.8%0.076% 8/13/2021Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704% 8/13/2021Geode Capital Management LLC100,196$196K0.0%+64.8%0.395% 8/13/2021Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363% 8/11/2021Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079% (Data available from 1/1/2016 forward) CNSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNSP shares? During the previous two years, 10 institutional investors and hedge funds held shares of CNS Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($335K), Smith Anglin Financial LLC ($64K), Jane Street Group LLC ($51K), Geode Capital Management LLC ($47K), Citadel Advisors LLC ($39K), XTX Topco Ltd ($36K), and Connective Capital Management LLC ($34K).Learn more on CNS Pharmaceuticals' institutional investors. What percentage of CNS Pharmaceuticals' stock is owned by institutional investors? 14.02% of CNS Pharmaceuticals' stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings. Which institutional investors have been buying CNS Pharmaceuticals' stock? Of the 10 institutional investors that purchased CNS Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($528K), Jane Street Group LLC ($396.58K), Citadel Advisors LLC ($321.87K), XTX Topco Ltd ($294.92K), Connective Capital Management LLC ($280.06K), Integrated Wealth Concepts LLC ($250K), and Wealthfront Advisers LLC ($216.05K). How much institutional buying is happening at CNS Pharmaceuticals? Institutional investors have bought a total of 2,349,355 shares in the last 24 months. This purchase volume represents approximately $144.41M in transactions. Related Companies LSTA Institutional Ownership CING Institutional Ownership HOTH Institutional Ownership APLM Institutional Ownership EDSA Institutional Ownership SYBX Institutional Ownership ASBP Institutional Ownership BLRX Institutional Ownership THAR Institutional Ownership PULM Institutional Ownership This page (NASDAQ:CNSP) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
